Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 9 M10 M10 M11 M11 M11 M 43 M Research & development —————— — Operating income -1.13 B-412 M-16 M471 M741 M746 M 1.94 B Non-Operating Income, Total -81 M-274 M688 M789 M-433 M379 M 1.42 B Interest expense, net of interest capitalized 687 M668 M755 M738 M731 M709 M 2.93 B Non-Operating Income, excl. Interest Expenses -81 M-274 M-67 M51 M-1.16 B-330 M -1.51 B Unusual income/expense —————— — Pretax income -1.21 B-686 M672 M1.26 B308 M1.13 B 3.37 B Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 50 M-140 M806 M954 M-148 M654 M 2.27 B Discontinued operations —————— — Net income 50 M-140 M806 M954 M-148 M654 M 2.27 B Dilution adjustment 000000 0 Preferred dividends 35 M38 M42 M46 M44 M44 M 176 M Diluted net income available to common stockholders 15 M-178 M764 M908 M-192 M610 M 2.09 B Basic earnings per share (Basic EPS) 0.02-0.170.730.9-0.170.53 1.99 Diluted earnings per share (Diluted EPS) 0.02-0.170.720.9-0.170.52 1.97 Average basic shares outstanding 918.3 M1.02 B1.05 B1.02 B1.12 B1.16 B — Diluted shares outstanding 921.9 M1.02 B1.06 B1.02 B1.12 B1.16 B — EBITDA 739 M-1.05 B-714 M-216 M62 M84 M -784 M EBIT -1.81 B-1.08 B-771 M-267 M10 M37 M -991 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 39 M30 M57 M51 M52 M47 M 207 M